Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

Desolvation of finasteride depends on environment and technique.

Finasteride exposure harms tadpole reproduction and hormone balance.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

Certain adrenal hormones can strongly stimulate oil gland growth in hamster skin, similar to male hormones.

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.

Thicker hair grows faster; hair loss patients have slower growth.

Finasteride microspheres help reduce hair loss for up to eight weeks with fewer side effects.

Medications for PCOS don't seem to raise heart disease risk.

Finding new uses for existing drugs is promising and can lead to safer, more effective medicines.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Better hair loss models needed for research.

Hair follicles could be used to deliver drugs effectively, with the right understanding and methods.

PCOS is common in young women, especially those aged 21-30, and often involves symptoms like irregular periods, weight gain, and acne.

There is a significant relationship between androgenic alopecia, hypertension, and diabetes mellitus.

Women with keloid scars often have acne and hair loss, especially those with "true" keloids, indicating a possible hormonal imbalance.

Antiandrogens help treat hormone-related conditions in both men and women.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Women of child-bearing age with androgenic alopecia lose hair density, especially in certain areas, and their hair becomes thinner. They also lose more than twice as much hair as healthy women.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Combining light therapy with certain substances improves hair growth in people with hair loss.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

The engineered yeast strain BLYAS can quickly and sensitively detect androgenic chemicals.

Soy supplements improve various skin conditions and aging signs, with topical use boosting skin barrier function.